Get started
Author

A Greenhalgh

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
2021 · Rachael A Evans, Hamish J C McAuley, et al. · The Lancet Respiratory Medicine · 672
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
2022 · R A Evans, O C Leavy, et al. · The Lancet Respiratory Medicine · 413
PDF
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
2022 · Felicity Liew, Shubha Talwar, et al. · EBioMedicine · 121
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
2023 · Callum Jackson, Iain D Stewart, et al. · The Lancet Respiratory Medicine · 35
Accelerated immune ageing is associated with COVID-19 disease severity
2024 · Janet M. Lord, Tonny Veenith, et al. · Immunity & Ageing · 34
PDF
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
2023 · Bang Zheng, Giulia Vivaldi, et al. · The Lancet Regional Health - Europe · 29
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
2023 · Hamish J.C. McAuley, Rachael A. Evans, et al. · EClinicalMedicine · 24
PDF
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
2023 · Omer Elneima, Hamish J C McAuley, et al. · International Journal of Epidemiology · 23
PDF
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury
2023 · Maxime Taquet, Zuzanna Skorniewska, et al. · Brain Communications · 14
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2024 · RECOVERY Collaborative Group, Peter Sandercock, et al. · Nature Communications · 11
PDF
Long COVID research: an update from the PHOSP-COVID Scientific Summit
2023 · Christopher E Brightling, Rachael A Evans, et al. · The Lancet Respiratory Medicine · 11
PDF
How long is Long-COVID? Symptomatic improvement between 12 and 18 months in a prospective cohort study
2023 · Robert M Barker-Davies, O O’Sullivan, et al. · BMJ Military Health · 8
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases
PDF
P173 Prognostic factors for survival in idiopathic pulmonary arterial hypertension
2017 · CR Popplewell, A Greenhalgh, et al.
PDF
Works count: 20
Citation count: 1,491
H-index: 12
I10-index: 14
Year
Topic
Type